Nuveen Asset Management, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 129 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$4,770,558
+33.4%
3,223,350
+30.7%
0.00%0.0%
Q4 2023$3,576,670
+34.6%
2,466,668
+0.3%
0.00%0.0%
Q3 2023$2,656,834
-16.2%
2,460,032
+0.1%
0.00%0.0%
Q2 2023$3,169,888
+87224.7%
2,457,278
-10.6%
0.00%0.0%
Q1 2023$3,630
-10.9%
2,750,119
+1.2%
0.00%
-50.0%
Q4 2022$4,075
-99.8%
2,716,261
+20.3%
0.00%
+100.0%
Q3 2022$2,663,000
-23.9%
2,257,471
-27.1%
0.00%0.0%
Q2 2022$3,498,000
-73.9%
3,095,642
-25.3%
0.00%
-75.0%
Q1 2022$13,393,000
+12.1%
4,146,441
-8.1%
0.00%0.0%
Q4 2021$11,951,000
-18.9%
4,509,682
+11.1%
0.00%
-20.0%
Q3 2021$14,732,000
-18.5%
4,058,183
-2.6%
0.01%0.0%
Q2 2021$18,084,000
+60.3%
4,167,028
+26.4%
0.01%
+25.0%
Q1 2021$11,278,000
+324.3%
3,297,800
+334.3%
0.00%
+300.0%
Q4 2020$2,658,000
+41.8%
759,408
-2.8%
0.00%0.0%
Q3 2020$1,874,000
+34.1%
780,979
+2.3%
0.00%0.0%
Q2 2020$1,397,000
+48.5%
763,328
+26.6%
0.00%
Q1 2020$941,000
-29.4%
602,735
-3.2%
0.00%
-100.0%
Q4 2019$1,332,000
+14.4%
622,4010.0%0.00%
Q3 2019$1,164,000
-32.4%
622,401
-5.6%
0.00%
-100.0%
Q2 2019$1,722,000659,5560.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders